Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs

Name: Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

As a regulator, Health Canada plays an important role in protecting the health and safety of Canadians. Health Canada is committed to being transparent and open about its activities and to making timely and useful information available about health products and health product submissions. Greater transparency and openness with Canadians strengthens the trust in our regulatory decisions, and ultimately supports Canadians in making better decisions about their health.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2023-12-24

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs (English, HTML) HTML
Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs (French, HTML) HTML

Related open data

Health Canada